Xu Y - Search Results

1

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.

Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, Fan J. Yang XR, et al. Among authors: xu y. Clin Cancer Res. 2009 Sep 1;15(17):5518-27. doi: 10.1158/1078-0432.CCR-09-0151. Epub 2009 Aug 25. Clin Cancer Res. 2009. PMID: 19706825

2

Establishment of green fluorescent protein-expressing hepatocellular carcinoma cell lines with different metastatic potential: relevant models for in vivo monitoring of metastasis and angiogenesis.

Xu Y, Sun HC, Tian B, Li Y, Chen J, Chen J, Gao DM, Xue Q, Tang ZY. Xu Y, et al. J Cancer Res Clin Oncol. 2004 Jul;130(7):375-82. doi: 10.1007/s00432-004-0551-1. J Cancer Res Clin Oncol. 2004. PMID: 15133661

3

FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma.

Lee TK, Man K, Ho JW, Wang XH, Poon RT, Xu Y, Ng KT, Chu AC, Sun CK, Ng IO, Sun HC, Tang ZY, Xu R, Fan ST. Lee TK, et al. Among authors: xu r, xu y. Clin Cancer Res. 2005 Dec 1;11(23):8458-66. doi: 10.1158/1078-0432.CCR-05-0447. Clin Cancer Res. 2005. PMID: 16322309

4

Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential.

Zhang T, Sun HC, Xu Y, Zhang KZ, Wang L, Qin LX, Wu WZ, Liu YK, Ye SL, Tang ZY. Zhang T, et al. Among authors: xu y. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8557-63. doi: 10.1158/1078-0432.CCR-05-0944. Clin Cancer Res. 2005. PMID: 16361537

5

[Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria].

Fan J, Zhou J, Xu Y, Qiu SJ, Wu ZQ, Yu Y, Huang XW, Tang ZY, Wang YQ. Fan J, et al. Among authors: xu y. Zhonghua Yi Xue Za Zhi. 2006 May 16;86(18):1227-31. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16796876 Chinese.

6

A novel peptide that selectively binds highly metastatic hepatocellular carcinoma cell surface is related to invasion and metastasis.

Jia WD, Sun HC, Zhang JB, Xu Y, Qian YB, Pang JZ, Wang L, Qin LX, Liu YK, Tang ZY. Jia WD, et al. Among authors: xu y. Cancer Lett. 2007 Mar 18;247(2):234-42. doi: 10.1016/j.canlet.2006.04.009. Epub 2006 Jun 27. Cancer Lett. 2007. PMID: 16806673

7

[Indications of liver transplantation for hepatocellular carcinoma patients].

Fan J, Xu Y. Fan J, et al. Among authors: xu y. Zhonghua Gan Zang Bing Za Zhi. 2006 Jul;14(7):536-7. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16867279 Chinese. No abstract available.

8

P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma.

Qian YB, Zhang JB, Wu WZ, Fang HB, Jia WD, Zhuang PY, Zhang BH, Pan Q, Xu Y, Wang L, Tang ZY, Sun HC. Qian YB, et al. Among authors: xu y. Cancer. 2006 Oct 1;107(7):1562-9. doi: 10.1002/cncr.22206. Cancer. 2006. PMID: 16948122 Free article.

9

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY. Gao Q, et al. Among authors: xu y. J Clin Oncol. 2007 Jun 20;25(18):2586-93. doi: 10.1200/JCO.2006.09.4565. J Clin Oncol. 2007. PMID: 17577038

10

[Influence of tumor characteristics on the outcome of liver transplantation among patients with hepatocellular carcinoma].

Xu Y, Fan J, Zhou J, Qiu SJ, Wu ZQ, Yu Y, Hang XW, Tang ZY, Wang YQ. Xu Y, et al. Zhonghua Yi Xue Za Zhi. 2007 Aug 14;87(30):2101-4. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17988527 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,088 results

Search Page

Filters